SAMABRIVA
France
- Amiens, Hauts-de-France
- 13/12/2023
- Unknown
- $4,313,000
Samabriva Biotechnology is a company that is creating a new method for producing biopharmaceuticals, chemicals, and biotech products using plants. Samabriva’s flexible platform combines the benefits of plant-based systems and traditional biomanufacturing techniques. By developing and cultivating high-yield plant clones in large-scale bioreactors it is possible to produce large quantities of high-value products more efficiently than traditional manufacturing methods.
- Industry Biotechnology Research
- Website https://samabriva.com/
- LinkedIn https://www.linkedin.com/company/samabriva/about/
Related People
Marina GuilletFounder
France -
Greater Nantes Metropolitan Area
Samabriva Biotechnology is a company that is creating a new method for producing biopharmaceuticals, chemicals, and biotech products using plants. Samabriva’s flexible platform combines the benefits of plant-based systems and traditional biomanufacturing techniques. By developing and cultivating high-yield plant clones in large-scale bioreactors it is possible to produce large quantities of high-value products more efficiently than traditional manufacturing methods.
Kilo Code | $8,000,000 | (Dec 11, 2025)
Surf AI | $15,000,000 | (Dec 11, 2025)
Bobyard | $35,000,000 | (Dec 11, 2025)
Empromptu.ai | $2,000,000 | (Dec 11, 2025)
Radial | $50,000,000 | (Dec 11, 2025)
Channel3( YC S25) | $6,000,000 | (Dec 11, 2025)
D3 Bio | $108,000,000 | (Dec 11, 2025)
Sprouty | $550,000 | (Dec 11, 2025)
Fresco | $17,550,941 | (Dec 11, 2025)
BoodleBox | $5,000,000 | (Dec 11, 2025)
CoreOps.AI | $3,500,000 | (Dec 10, 2025)
BON Credit | $3,500,000 | (Dec 10, 2025)